<DOC>
	<DOC>NCT03026192</DOC>
	<brief_summary>Using cerebral and renal near infrared spectroscopy monitoring to determine PDA closure in preterm infants after completing medical treatment for a hemodynamically significant PDA.</brief_summary>
	<brief_title>Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure</brief_title>
	<detailed_description />
	<mesh_term>Ductus Arteriosus, Patent</mesh_term>
	<criteria>preterm infants less than 32 weeks gestation infection, congenital heart disease, syndromic anomalies, and perinatal asphyxia.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Week</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>